By Taylor Washburn ( June 15, 2017, 2:40 PM EDT) -- In Brennan v. Zafgen Inc., 853 F.3d 606, (1st Cir., April 7, 2017), the First Circuit affirmed a District of Massachusetts decision dismissing claims against Zafgen Inc., a biopharmaceutical developer, and its CEO, Dr. Thomas Hughes. Judge Norman Stahl, writing for a panel that included retired U.S. Supreme Court Justice David Souter (sitting by designation), concluded that the plaintiffs' complaint did not allege facts giving rise to the "cogent and compelling" inference of scienter required by the Reform Act. Id. at *609 (quoting Tellabs Inc. v. Makor Issues & Rights Ltd., 551 U.S. 308, 324 (2007)). The Brennan opinion reaffirmed a vital point about scienter that is often misunderstood — namely, where a plaintiff alleges a defendant did not disclose a material fact, it is not enough for that plaintiff to establish that the defendant was aware of the fact. Rather, scienter requires that the defendant knew that omission of this fact risked misleading investors....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.